Briacell Therapeutics Corp (BCT) Director Rahoul Sharan Sells 106,000 Shares of Stock

Briacell Therapeutics Corp (CVE:BCT) Director Rahoul Sharan sold 106,000 shares of the business’s stock in a transaction on Friday, March 16th. The shares were sold at an average price of C$0.13, for a total transaction of C$13,780.00.

Shares of Briacell Therapeutics Corp (CVE:BCT) traded up C$0.01 during trading hours on Friday, hitting C$0.13. 616,500 shares of the stock traded hands, compared to its average volume of 159,749. Briacell Therapeutics Corp has a 52 week low of C$0.10 and a 52 week high of C$0.23. The firm has a market cap of $12.93, a P/E ratio of -4.33 and a beta of 0.80.

TRADEMARK VIOLATION NOTICE: This story was originally posted by Ticker Report and is the sole property of of Ticker Report. If you are accessing this story on another domain, it was illegally copied and reposted in violation of U.S. and international trademark & copyright law. The correct version of this story can be read at https://www.tickerreport.com/banking-finance/3272796/briacell-therapeutics-corp-bct-director-rahoul-sharan-sells-106000-shares-of-stock.html.

About Briacell Therapeutics

BriaCell Therapeutics Corp is Canada-based immuno-oncology Biotechnology Company, which is developing Bria-IMT, a targeted immunotherapy for the treatment of breast cancer. Bria-IMT has demonstrated Phase-I safety and efficacy data in patients with advanced breast cancers and is conducting a Phase I/IIa clinical trial for Bria-IMT.

Receive News & Ratings for Briacell Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Briacell Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Rubycoin  Market Capitalization Achieves $15.18 Million
Rubycoin Market Capitalization Achieves $15.18 Million
Oaktree Specialty Lending  vs. Nelnet  Head to Head Review
Oaktree Specialty Lending vs. Nelnet Head to Head Review
Head-To-Head Review: AAC  & BioTelemetry
Head-To-Head Review: AAC & BioTelemetry
Copart  & The Competition Head to Head Review
Copart & The Competition Head to Head Review
First Industrial Realty Trust  Releases FY18 Earnings Guidance
First Industrial Realty Trust Releases FY18 Earnings Guidance
Alliance Resource Partners  Sets New 52-Week High and Low at $16.25
Alliance Resource Partners Sets New 52-Week High and Low at $16.25


© 2006-2018 Ticker Report. Google+.